CymitQuimica logo
Señalización PI3K / Akt / mTOR

Señalización PI3K / Akt / mTOR

Los inhibidores de la señalización PI3K/Akt/mTOR son compuestos que se dirigen a las vías de la fosfoinositida 3-cinasa (PI3K), la cinasa Akt y el blanco de la rapamicina en mamíferos (mTOR). Estas vías son reguladores críticos del crecimiento celular, la supervivencia, el metabolismo y la autofagia, lo que las convierte en objetivos clave en la investigación del cáncer y los trastornos metabólicos. Inhibir estas vías puede ayudar a controlar el crecimiento y la proliferación tumoral, ofreciendo potenciales estrategias terapéuticas para varios tipos de cáncer y otras enfermedades caracterizadas por una señalización celular desregulada. En CymitQuimica, ofrecemos una amplia selección de inhibidores de alta calidad de PI3K/Akt/mTOR para apoyar su investigación en oncología, señalización celular y enfermedades metabólicas.

Subcategorías de "Señalización PI3K / Akt / mTOR"

Mostrar 2 subcategorías más

Se han encontrado 1038 productos de "Señalización PI3K / Akt / mTOR"

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • EGFR/PI3Kα-IN-1


    <p>EGFR/PI3Kα-IN-1 (compound 30k), a dual EGFR/PI3Kα inhibitor, exhibits potent activity with IC 50 values of 3.6 nM (EGFRL858R/T790M) and 30 nM (PI3Kα). It effectively inhibits tumor cell proliferation and demonstrates significant anticancer activity.</p>
    Fórmula:C50H49N11O5S
    Forma y color:Solid
    Peso molecular:916.06
  • mTOR inhibitor WYE-28

    CAS:
    <p>Compound 28 (mTOR inhibitor WYE-28) is a selective inhibitor of mTOR (IC50=0.08 nM). Also inhibits PI3Kα (IC50 6 nM).</p>
    Fórmula:C30H34N8O5
    Forma y color:Solid
    Peso molecular:586.653
  • EGFR-IN-162


    <p>EGFR-IN-162 (compound 20) is an effective EGFR inhibitor that enhances both early and late apoptosis (EGFR) as well as necrosis (necrosis). It shows potential for use in breast cancer research.</p>
    Fórmula:C27H31N3O2
    Forma y color:Solid
    Peso molecular:429.24163
  • Lumretuzumab

    CAS:
    <p>Lumretuzumab (RG-7116) is a humanized anti-HER3 monoclonal antibody with antitumor activity.</p>
    Pureza:95.3% (SDS-PAGE); 96.4% (SEC-HPLC) - 95.3% (SDS-PAGE); 96.4% (SEC-HPLC)
    Forma y color:Liquid
  • PI3K-IN-22

    CAS:
    <p>PI3K-IN-22 is a dual kinase inhibitor of PI3Kα and mTOR, with IC50s of 0.9 and 0.6 nM respectively. PI3K-IN-22 could be used in cancer.</p>
    Fórmula:C31H35F3N8O3
    Forma y color:Solid
    Peso molecular:624.66
  • PI3Kα-IN-25


    <p>PI3Kα-IN-25 (Compound Djh1) is a selective inhibitor of PI3Kα, suitable for research in triple-negative breast cancer.</p>
    Fórmula:C21H19ClN4O4
    Forma y color:Solid
    Peso molecular:426.853
  • RMC-4529

    CAS:
    <p>RMC-4529 is a chemical compound that demonstrates potent inhibition, with an IC50 value of 1.0 nM, against p-4E-BP1-(T37/46) in mTOR kinase cellular assays.</p>
    Fórmula:C90H139N13O23
    Forma y color:Solid
    Peso molecular:1771.17
  • Pertuzumab

    CAS:
    <p>Pertuzumab (anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2</p>
    Pureza:98.00%
    Forma y color:Liquid
    Peso molecular:148 kDa
  • GSK-3β inhibitor 19


    <p>GSK-3β Inhibitor 19 (compound 36) is an inhibitor of GSK-3β with an IC50 value of 70 nM. It is applicable in research related to anti-inflammatory and Alzheimer's disease.</p>
    Fórmula:C15H12N4O2S
    Forma y color:Solid
    Peso molecular:312.35
  • AMX-818


    <p>AMX-818 is a conditionally activated, masked T cell engager (TCE) that targets HER2. It demonstrates potent T cell cytotoxicity against HER2-positive tumor cell lines and can induce tumor regression in vivo. AMX-818 holds promise for research into HER2-positive solid tumors.</p>
    Forma y color:Odour Liquid
  • WAY-270360

    CAS:
    <p>WAY-270360 (N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide) is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.</p>
    Fórmula:C22H19N3O3
    Pureza:98.05%
    Forma y color:Solid
    Peso molecular:373.4
  • MS9427 TFA


    <p>MS9427 TFA: PROTAC EGFR degrader, Kd 7.1 nM (WT), 4.3 nM (L858R), targets mutant EGFR, inhibits NSCLC cell growth, for cancer research.</p>
    Fórmula:C50H59ClF4N8O14
    Forma y color:Solid
    Peso molecular:1107.5
  • IHMT-PI3K-315


    <p>IHMT-PI3K-315 (20e) serves as a potent, selective inhibitor of PI3Kγ/δ, exhibiting IC 50 values of 4.0 nM for PI3Kγ and 9.1 nM for PI3Kδ. Additionally, it demonstrates antitumor activity.</p>
    Fórmula:C22H20F2N6O4
    Forma y color:Solid
    Peso molecular:470.43
  • GSK-3 Inhibitor 5

    CAS:
    <p>4-Cyanophenacyl bromide, a ketone, used in drug-making and organic synthesis, blocks GSK-3.</p>
    Fórmula:C9H6BrNO
    Pureza:99.58%
    Forma y color:Off-White To Light Yellow Crystalline Powder
    Peso molecular:224.05
  • EGFR-IN-76

    CAS:
    <p>EGFR-IN-76 is a potent EGFR inhibitor.</p>
    Fórmula:C30H30ClFN6O2
    Pureza:97.02% - 97.72%
    Forma y color:Solid
    Peso molecular:561.05
  • EGFR/VEGFR2-IN-5


    <p>EGFR/VEGFR2-IN-5 (Compound 14) is an orally active dual inhibitor of EGFR and VEGFR2, exhibiting an IC50 value of 1.15 µM for VEGFR2 and 0.28 µM for EGFRT790M. This compound demonstrates significant anticancer activity.</p>
    Fórmula:C17H15N7O5S
    Forma y color:Solid
    Peso molecular:429.41
  • GW 583340

    CAS:
    <p>GW 583340 is a potent and selective dual inhibitor of EGFR/ErbB2 tyrosine kinase with the advantage of oral dosability and antitumor effects.</p>
    Fórmula:C28H25ClFN5O3S2
    Pureza:98.68%
    Forma y color:Soild
    Peso molecular:598.11
  • Simotinib hydrochloride

    CAS:
    <p>Simotinib hydrochloride: selective oral EGFR inhibitor, IC50 19.9 nM, potent anticancer agent.</p>
    Fórmula:C25H27Cl2FN4O4
    Forma y color:Solid
    Peso molecular:537.41
  • Lyso-Monosialoganglioside GM3

    CAS:
    <p>Lyso-Monosialoganglioside GM3 (Lyso-GM3) is an analog of Ganglioside GM3 with antitumor properties. It inhibits the increase in EGFR kinase activity induced by EGF in A431 epithelial cancer cells.</p>
    Fórmula:C41H74N2O20
    Forma y color:Solid
    Peso molecular:915.028
  • EGFR-TK-IN-5


    <p>EGFR-TK-IN-5 (Compound NCE 2) is a thiazolyl pyrazoline derivative with significant inhibitory activity and stability against EGFR. It is applicable in tumor research.</p>
    Fórmula:C26H20ClFN4OS
    Forma y color:Solid
    Peso molecular:490.98